Connor, Clark & Lunn Investment Management (CC&L)’s Trillium Therapeutics Inc. TRIL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-20,200
| Closed | -$355K | – | 1263 |
|
|
2021
Q3 | $355K | Sell |
20,200
-322,300
| -94% | -$5.66M | ﹤0.01% | 838 |
|
|
2021
Q2 | $3.32M | Sell |
342,500
-27,400
| -7% | -$265K | 0.02% | 442 |
|
|
2021
Q1 | $3.96M | Buy |
369,900
+169,400
| +84% | +$1.81M | 0.02% | 411 |
|
|
2020
Q4 | $2.95M | Buy |
+200,500
| New | +$2.95M | 0.02% | 431 |
|